Patients with gout at increased risk for cardiovascular disease and adverse event
The Rheumatologist: July 2010
Information on New Approvals and Medication Safety
Epidemiologist and ARHP member Lieutenant Colonel Robert Campbell, PhD, is currently serving as a member of the U.S. Air Force Reserve on a biometric team that assists senior officials of the Government of the Islamic Republic of Afghanistan, USAID, the U.S. Embassy, and other military organizations in the development of plan for the recruitment of biometric enrollment technicians and the identification of a secure national database to support a revised Afghan National Identification card, the “New Tazkira.”
ACR member Victoria Seligman, MD, of the departments of medicine and rheumatology at the VA Medical Center in Denver, received the Golden Apple Award from Health Volunteers Overseas (HVO) for her commitment to providing education and training in developing countries.
To meet the ever-changing scope of practice for rheumatology health professionals, the ARHP has created a new Practice Committee to provide the tools you need to advance your practice.
This year marks the second year of CMS’ electronic prescribing incentive program for office-based physicians.
At its February meeting, the ACR board of directors approved the Model Biologics Policy, which will be used when discussing guidelines and patients’ quality of treatment with health insurance companies.
With the elimination of consultation codes by the Centers for Medicare and Medicaid Services (CMS), many rheumatology practices are finding it a heavy burden to bill the appropriate codes for the time they spend with patients.
The ACR/ARHP Annual Scientific Meeting is the premier event for specialists in the field of rheumatology. At this year’s meeting, basic researchers will have multiple opportunities to increase their knowledge, and there will be something for every interest.
July’s Coding Challenge
July’s Coding Answer
Research is critically important to find cures and accelerate patient care for the millions who suffer from arthritis and rheumatic disease. Despite its prevalence in the population and recent treatment advances, rheumatoid arthritis (RA) remains an incurable disease and receives disproportionately less research funding from federal sources than most other autoimmune diseases. This is precisely why the ACR Research and Education Foundation (REF) launched Within Our Reach: Finding a Cure for Rheumatoid Arthritis to directly invest in the types of innovative research not being done elsewhere in the country.
Amidst the most momentous week of the year’s tumultuous healthcare reform activities, we arrived in Washington, D.C., for the annual ACR Advocates for Arthritis Capitol Hill Fly-In. This was to be my first visit to Congress. Although my alma mater, Georgetown University, was a short distance from the Capitol dome, as a student I had little interest in the political process—particularly as it related to medicine. Now, however, as a young rheumatologist, I am increasingly aware of the impact health policy has on my daily practice. I have also watched the healthcare reform debate unfold over the last year, recognizing that this is a critical time for physicians to be vocal and active. There is a great deal at stake, and we are surrounded daily by the very issues debated in Washington. Why not take our opinions directly to the decision makers?
How the ACR manages conflict-of-interest policies
Travel woes and a journey through Europe
The ACR is increasing the ranks of rheumatology on many fronts
Understand the challenges in rheumatology today
Is it the end of the tunnel or an oncoming train?
Tracking patient manifestations of Behçet’s syndrome around the world